ITCI
Mirae Asset Global Investments’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,560
| Closed | -$469K | – | 1663 |
|
|
2025
Q1 | $469K | Buy |
3,560
+27
| +0.8% | +$3.56K | ﹤0.01% | 937 |
|
|
2024
Q4 | $300K | Sell |
3,533
-289
| -8% | -$24.5K | ﹤0.01% | 1006 |
|
|
2024
Q3 | $280K | Buy |
3,822
+670
| +21% | +$49.1K | ﹤0.01% | 1034 |
|
|
2024
Q2 | $224K | Sell |
3,152
-40,602
| -93% | -$2.88M | ﹤0.01% | 1037 |
|
|
2024
Q1 | $2.48M | Sell |
43,754
-1,875
| -4% | -$106K | 0.01% | 1090 |
|
|
2023
Q4 | $3.27M | Buy |
45,629
+146
| +0.3% | +$10.5K | 0.01% | 1050 |
|
|
2023
Q3 | $2.37M | Buy |
45,483
+2,434
| +6% | +$127K | 0.01% | 1110 |
|
|
2023
Q2 | $2.73M | Sell |
43,049
-167
| -0.4% | -$10.6K | 0.01% | 1067 |
|
|
2023
Q1 | $2.34M | Sell |
43,216
-61
| -0.1% | -$3.3K | 0.01% | 1141 |
|
|
2022
Q4 | $2.29M | Sell |
43,277
-1,374
| -3% | -$72.7K | 0.01% | 1084 |
|
|
2022
Q3 | $2.08M | Buy |
44,651
+14,482
| +48% | +$674K | 0.01% | 1113 |
|
|
2022
Q2 | $1.72M | Buy |
+30,169
| New | +$1.72M | ﹤0.01% | 1185 |
|